Zoomedia, Inc.: Client News

Marina Biotech Announces Closing of $1.5 MM Bridge Loan

Fri, 10 Feb 2012 11:31:00 +0000

BOTHELL, WA, Feb 10, 2012 (MARKETWIRE via COMTEX) --Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced the closing of a bridge loan pursuant to a Note and Warrant Purchase Agreement. Under the terms of the loan, the Company sold promissory notes in the aggregate principal amount of $1.5 million and issued warrants to purchase an aggregate of approximately 3.7 million shares of the Company's common stock at $0.508 per share to certain accredited investors. "As we continue to execute on our business strategy, this capital allows us necessary resources to achieve our first quarter objectives and provides us with t...

InterMune Reports Fourth Quarter and Full Year 2011 Financial Results and Business Highlights

Thu, 09 Feb 2012 21:00:00 +0000

BRISBANE, Calif., Feb. 9, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the fourth quarter and full year ended December 31, 2011.

InterMune Names Jonathan A. Leff, M.D., as Executive Vice President of Research and Development

Thu, 09 Feb 2012 21:00:00 +0000

BRISBANE, Calif., Feb. 9, 2012 /PRNewswire/ --

Celldex Therapeutics to Participate on Therapeutic Workshop Panel at the BIO CEO & Investor Conference

Thu, 09 Feb 2012 14:00:00 +0000

NEEDHAM, Mass.--(BUSINESS WIRE)--Feb. 9, 2012-- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will participate with other industry executives in a therapeutic workshop panel discussion titled Drugs Need Friends Too

Codexis Reports Fourth Quarter and Full Year 2011 Results

Tue, 07 Feb 2012 21:05:00 +0000

49% Annual Increase in Pharmaceutical Product Sales CodeXyme

BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012

Mon, 06 Feb 2012 11:45:00 +0000

BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012

InterMune to Release Fourth Quarter and Full Year Financial Results on February 9

Thu, 02 Feb 2012 21:01:00 +0000

BRISBANE, Calif., Feb. 2, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its fourth quarter and full year 2011 financial results at the close of the U.S. markets on Thursday, February 9, 2012.

ARIAD to Present at Upcoming Investor Conferences

Thu, 02 Feb 2012 12:35:00 +0000

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 2, 2012-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company

Marina Biotech Begins Trading on the OTCQX Tier of OTC Market

Thu, 02 Feb 2012 00:56:00 +0000

BOTHELL, WA, Feb 01, 2012 (MARKETWIRE via COMTEX) --Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the Company's common stock will begin trading on the OTCQX tier of the OTC Markets commencing on Thursday, February 2, 2012. The Company has been advised that its shares will trade under its current symbol, "MRNA". Investors will be able to view real-time stock quotes for "MRNA" at http://www.otcmarkets.com/stock/MRNA/quote. "Marina Biotech and NASDAQ have worked hard together over the past several years to find ways of maintaining the Company's listing on The NASDAQ Stock Market," stated J. Michael French...

Codexis to Present at the Pacific Crest and Jefferies Conferences

Wed, 01 Feb 2012 13:00:00 +0000

REDWOOD CITY, Calif., Feb. 1, 2012 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS), a leading producer of enzymes to enable affordable and abundant sugar for the production of fuels and chemicals, today announced that the company will be participating in the following upcoming investor conferences: Pacific Crest Emerging Technology Summit Date: Wednesday, February 15, 2012